Cargando…
Efficacy and safety of zoledronic acid in the treatment of glucocorticoid-induced osteoporosis
Glucocorticoids are essential in treating many disorders and they are widely used in spite of their negative impact on the skeletal system. As bisphosphonates reduce bone resorption through their action on osteoclasts, they play an important role in management of glucocorticoid-induced osteoporosis....
Autores principales: | Serefoglu, Ege Can, Tandogdu, Zafer |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2878955/ https://www.ncbi.nlm.nih.gov/pubmed/20526439 |
Ejemplares similares
-
Safety and Efficacy of Zoledronic Acid Treatment with and without Acetaminophen and Eldecalcitol for Osteoporosis
por: Mochizuki, Takeshi, et al.
Publicado: (2021) -
Synergistic effect of graphene oxide and zoledronic acid for osteoporosis and cancer treatment
por: Boran, Gökçen, et al.
Publicado: (2020) -
Zoledronic acid infusion for prevention and treatment of osteoporosis
por: Sunyecz, John A
Publicado: (2010) -
Role of zoledronic acid in the prevention and treatment of osteoporosis
por: Räkel, Agnès, et al.
Publicado: (2011) -
Safety and tolerability of zoledronic acid and other bisphosphonates in osteoporosis management
por: Dalle Carbonare, Luca, et al.
Publicado: (2010)